This test is most useful if any of these apply to you.
Urinary CML can give you an exploratory read on a narrow kind of chemical wear. It captures a specific damaged molecule your body clears in urine, and the amount partly tracks what you eat, what your tissues are breaking down, and how well your kidneys are clearing small waste products.
This is a research-grade test with no agreed-upon normal cutoffs yet. That makes trending useful, but only if you collect samples under similar conditions and read the result next to kidney and metabolic markers.
Nε-(carboxymethyl)lysine, usually shortened to CML, is a chemically altered form of lysine. Lysine is a protein building block.
Two paths create it. Sugar can attach to protein and change it. Reactive chemistry from normal energy use and inflammation can push that damage further. Scientists call many of these end products AGEs. CML is one of the AGEs measured most often.
This test measures free CML in urine. Free means it is no longer attached to a large protein. The lab usually uses a molecule-specific method and reports the result relative to urine creatinine, which helps account for how dilute the urine sample is. Some studies below used 24-hour urine, blood, or antibody assays. They are useful, but they are not identical to this spot urine measurement.
HbA1c tells you how much glucose has attached to hemoglobin over the life of your red blood cells. Urinary CML is different. It is a waste stream from CML-modified proteins and from dietary CML passing through your body.
The two are not stand-ins. One recent serum study in people with type 2 diabetes found lower serum CML with higher HbA1c in those without chronic kidney disease, while other studies have found different patterns in other tissues or groups. That is the point: CML is not a hidden glucose reading. It reflects a separate layer of glycation, diet, tissue turnover, and clearance.
Free CML is cleared mainly through the kidneys. If filtering capacity falls, serum CML can rise while urinary excretion can fall. So a low urine result is not automatically reassuring.
In 109 people with type 2 diabetes, kidney impairment was linked to higher serum CML and lower urinary CML excretion. In 630 kidney transplant recipients, lower 24-hour urinary CML excretion was tied to higher all-cause mortality. A low urinary value there did not mean less damage. It likely reflected kidney clearance, protein intake, muscle mass, and creatinine excretion. Read the urinary value as a clearance-and-turnover signal, not as a simple good-number or bad-number gauge.
The most relevant urine data are still group-level research, not individual diagnosis. In a 200-person study, urinary CML was higher in people classified as having impaired metabolic health. The vascular and kidney signals came more from other urinary markers.
Algorithms using age, BMI, fructosyl-lysine, and amino acid markers classified metabolic, vascular, and kidney impairment with about 72% to 90% accuracy in that dataset. CML alone did not produce that accuracy. The practical read: CML may add one voice to a panel, but it should not be treated as a standalone verdict.
Most cardiovascular outcome data come from blood CML, which is a different measurement from this urine test. In 2,111 older adults followed for about nine years, higher serum CML tracked with modestly higher rates of coronary heart disease and stroke, about 11% more risk for each standard step up in serum level, independent of diabetes and kidney markers.
Serum CML has also been linked to heart failure, atrial fibrillation, and advanced diabetic eye disease. But the blood evidence is mixed. In 450 people with diabetic kidney disease and hypertension, serum CML did not independently predict cardiovascular or kidney outcomes after adjustment. Treat these studies as reasons the underlying biology matters, not as proven predictions from your urine result.
Plasma free CML can rise after meals. In a small breakfast study, average free CML rose by about 17% and peaked around 90 minutes when meal data were pooled, but the study did not show a clear difference between breakfast types. Urine timing after a single meal is less settled.
A trajectory beats a snapshot. If you use this marker, repeat it under similar collection conditions. With your own series in hand, you have a better chance of separating a real shift from meal timing, kidney clearance, and day-to-day noise.
Diet is only one input, and the evidence is not one-sided. In the CODAM cohort, higher dietary AGE intake tracked with higher free urinary CML. But another careful study found no correlation between serum and urinary CML and concluded that eating foods high in CML is not a major determinant of either. Part of the reason is that gut bacteria break down a lot of dietary CML, and some CML may form in the intestine rather than come straight from food. So a high urinary value does not cleanly point back to your plate.
Do not act on one number. Repeat it under similar conditions, then read it with companion tests.
Pair it with cystatin C or eGFR, plus a urine albumin-to-creatinine ratio. Add HbA1c, fasting glucose, and insulin to judge the metabolic side, plus hs-CRP for inflammatory context. A low urinary CML with worsening kidney markers points toward a kidney workup. A higher urinary CML with high glucose or insulin points more toward metabolic stress or diet. The pattern across these markers should drive the next step.
Evidence-backed interventions that affect your CML level
Nε-(carboxymethyl)lysine is best interpreted alongside these tests.
Nε-(carboxymethyl)lysine is included in these pre-built panels.